These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16822721)

  • 41. Cardiovascular disease risk in youth with diabetes mellitus.
    Wadwa RP
    Rev Endocr Metab Disord; 2006 Sep; 7(3):197-204. PubMed ID: 17160723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin resistance, type 2 diabetes mellitus, and cardiovascular disease: the end of the beginning.
    Reaven G
    Circulation; 2005 Nov; 112(20):3030-2. PubMed ID: 16286599
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of the DiabetIMSS program on cardiovascular risk, blood pressure and HDL cholesterol in patients with metabolic syndrome].
    Mendoza-Romo MA; Montes-Acuña JF; Zavala-Cruz GG; Nieva-de Jesús RN; Ramírez-Arreola MC; Andrade-Rodríguez HJ
    Rev Med Inst Mex Seguro Soc; 2017; 55(1):32-39. PubMed ID: 28092245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A multitrait GWAS sheds light on insulin resistance.
    Heid IM; Winkler TW
    Nat Genet; 2016 Dec; 49(1):7-8. PubMed ID: 28029160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiovascular disease in diabetes.
    Bloomgarden ZT
    Diabetes Care; 2010 Apr; 33(4):e49-54. PubMed ID: 20351221
    [No Abstract]   [Full Text] [Related]  

  • 46. Metabolic domino: new concept in lifestyle medicine.
    Itoh H
    Drugs Today (Barc); 2006 Dec; 42 Suppl C():9-16. PubMed ID: 17245476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The metabolic syndrome and cardiovascular disease - an ongoing tsunami.
    Hanefeld M; Pistrosch F
    Pediatr Endocrinol Diabetes Metab; 2013; 20(1):5-11. PubMed ID: 25612864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Summaries for patients. Dietary trans-palmitoleic acid and diabetes.
    Ann Intern Med; 2010 Dec; 153(12):I-56. PubMed ID: 21173398
    [No Abstract]   [Full Text] [Related]  

  • 49. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.
    de Ferranti SD; de Boer IH; Fonseca V; Fox CS; Golden SH; Lavie CJ; Magge SN; Marx N; McGuire DK; Orchard TJ; Zinman B; Eckel RH
    Circulation; 2014 Sep; 130(13):1110-30. PubMed ID: 25114208
    [No Abstract]   [Full Text] [Related]  

  • 50. [Risk factors for cardiovascular disease. Results from the Swedish national diabetes register compared with international studies].
    Cederholm J; Eliasson B; Zethelius B; Eeg-Olofsson K; Gudbjörnsdottir S
    Lakartidningen; 2013 Apr 24-May 6; 110(17-18):882-5. PubMed ID: 23717939
    [No Abstract]   [Full Text] [Related]  

  • 51. Treating the Inflammatory Core of Metabolic Syndromes.
    EBioMedicine; 2015 Sep; 2(9):1003-4. PubMed ID: 26501087
    [No Abstract]   [Full Text] [Related]  

  • 52. [Metabolic syndrome: limited significance for clinical practice].
    Dekker JM; Diamant M; Nijpels G; Heine RJ
    Ned Tijdschr Geneeskd; 2005 Apr; 149(16):855-8. PubMed ID: 15868988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Are there differences in cardiovascular and metabolic risk profiles among men and women with Type2 diabetes? A cross-sectional analysis.
    Sridharan S; Gunathilake W; Fernando DJ; Idris I
    Diabet Med; 2010 Oct; 27(10):1212-4. PubMed ID: 20854390
    [No Abstract]   [Full Text] [Related]  

  • 54. Obesity and the insulin resistance syndrome.
    Dunger DB
    Arch Dis Child; 2005 Jan; 90(1):1. PubMed ID: 15613499
    [No Abstract]   [Full Text] [Related]  

  • 55. Cardiometabolic risk management in type 2 diabetes and obesity.
    Taylor AM
    Curr Diab Rep; 2008 Oct; 8(5):345-52. PubMed ID: 18778582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biochemical changes correlated with blood thiamine and its phosphate esters levels in patients with diabetes type 1 (DMT1).
    Al-Daghri NM; Alharbi M; Wani K; Abd-Alrahman SH; Sheshah E; Alokail MS
    Int J Clin Exp Pathol; 2015; 8(10):13483-8. PubMed ID: 26722561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular risk in double diabetes mellitus--when two worlds collide.
    Cleland SJ
    Nat Rev Endocrinol; 2012 Apr; 8(8):476-85. PubMed ID: 22488644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Insulin-resistance and cardiovascular risk].
    Dei Cas A; Spigoni V; Metra M; Dei Cas L
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):93S-97S. PubMed ID: 21416835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Letter by Stefan et al regarding article, "Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men".
    Stefan N; Fritsche A; Häring HU
    Circulation; 2010 Sep; 122(11):e456; author reply e457. PubMed ID: 20837935
    [No Abstract]   [Full Text] [Related]  

  • 60. Letter by McAuley et al regarding article, "Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men".
    McAuley PA; Sui X; Blair SN
    Circulation; 2010 Sep; 122(11):e455; author reply e457. PubMed ID: 20837934
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.